Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Buti

Showing results (21-30 of 1,279) with videos related to

Pageof 128
Sort By:
Journal of the American Academy of Nurse Practitioners|March 23, 1999
Herniated lumbar discs: diagnosis and managementR L Buti
Therapeutic Advances in Medical Oncology|October 5, 2017
Cabozantinib in metastatic renal cell carcinoma: latest findings and clinical potentialMelissa Bersanelli, Sebastiano Buti
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 3, 2022
What Is the Real Impact of Concomitant Antibiotics or Proton Pump Inhibitors on Efficacy of Atezolizumab-Based Regimens in Patients With NSCLC?Giulia Mazzaschi, Sebastiano Buti
Forum (Genoa, Italy)|March 16, 2000
What to do when standard therapy failsM Buti, R Esteban
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 27, 2017
Is Cabozantinib Really Better Than Sunitinib As First-Line Treatment of Metastatic Renal Cell Carcinoma?Sebastiano Buti, Melissa Bersanelli
Enfermedades Infecciosas Y Microbiologia Clinica|November 29, 2011
[New agents for the treatment of hepatitis C]Maria Buti, Maria Homs
Drugs|July 22, 2005
Drugs in development for hepatitis BMaria Buti, Rafael Esteban
Expert Review of Gastroenterology & Hepatology|December 15, 2012
Considerations for the long-term treatment of chronic hepatitis B with nucleos(t)ide analogsJörg Petersen, Maria Buti
Clinical and Molecular Hepatology|January 14, 2017
Management of direct antiviral agent failuresMaría Buti, Rafael Esteban
Expert Review of Gastroenterology & Hepatology|August 30, 2012
Tenofovir disoproxil fumarate in the treatment of chronic hepatitis BMaria Buti, Maria Homs
Pageof 128

Showing results (21-30 of 1,279) with videos related to

Sort By:
Pageof 128
Journal of the American Academy of Nurse Practitioners|March 23, 1999
Herniated lumbar discs: diagnosis and managementR L Buti
Therapeutic Advances in Medical Oncology|October 5, 2017
Cabozantinib in metastatic renal cell carcinoma: latest findings and clinical potentialMelissa Bersanelli, Sebastiano Buti
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 3, 2022
What Is the Real Impact of Concomitant Antibiotics or Proton Pump Inhibitors on Efficacy of Atezolizumab-Based Regimens in Patients With NSCLC?Giulia Mazzaschi, Sebastiano Buti
Forum (Genoa, Italy)|March 16, 2000
What to do when standard therapy failsM Buti, R Esteban
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 27, 2017
Is Cabozantinib Really Better Than Sunitinib As First-Line Treatment of Metastatic Renal Cell Carcinoma?Sebastiano Buti, Melissa Bersanelli
Enfermedades Infecciosas Y Microbiologia Clinica|November 29, 2011
[New agents for the treatment of hepatitis C]Maria Buti, Maria Homs
Drugs|July 22, 2005
Drugs in development for hepatitis BMaria Buti, Rafael Esteban
Expert Review of Gastroenterology & Hepatology|December 15, 2012
Considerations for the long-term treatment of chronic hepatitis B with nucleos(t)ide analogsJörg Petersen, Maria Buti
Clinical and Molecular Hepatology|January 14, 2017
Management of direct antiviral agent failuresMaría Buti, Rafael Esteban
Expert Review of Gastroenterology & Hepatology|August 30, 2012
Tenofovir disoproxil fumarate in the treatment of chronic hepatitis BMaria Buti, Maria Homs
Pageof 128